The NFX Podcast

NFXBio: TechBio Platforms Developing a Universal Vaccine & Beating Treatment-Resistant Cancer

11.22.2022 - By NFXPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

In this episode, Nick Goldner and Jacob Glanville share their founder journeys and discuss platform technologies in biotech. They delve into the business models of Resistance Bio and Sentivax, strategies for infectious diseases, and the challenges of scientific entrepreneurship. The conversation shifts to fundraising experiences and understanding investor feedback, concluding with visions for the future of biotech.

More episodes from The NFX Podcast